Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jan
27
2015
Will Promoted Video Pave the Way for Drug and Medical Device Promotion on Twitter? Epstein Becker & Green, P.C.
Aug
11
2022
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Apr
13
2015
Supreme Court Rules That Providers and Suppliers Cannot Challenge Medicaid Reimbursement Rates in Federal Court Epstein Becker & Green, P.C.
Oct
20
2015
D.C. District Court Vacates HRSA’s Interpretative Rule on Orphan Drugs Epstein Becker & Green, P.C.
Mar
7
2023
Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023 Epstein Becker & Green, P.C.
Dec
14
2015
California Imposes Controversial Cost-Sharing Restrictions to Facilitate Patient Access to Expensive Drugs Epstein Becker & Green, P.C.
Dec
30
2019
California Puts a Foot On the Scale to Drive Unionization Higher: AB 1291 Mandates State-Sponsored Assistance in Organizing Cannabis Employees Epstein Becker & Green, P.C.
May
2
2023
Unpacking Averages: Success Rates for FDA FOIAs by Topic and Requester Epstein Becker & Green, P.C.
Sep
5
2023
Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? Epstein Becker & Green, P.C.
May
12
2020
New York Employers: Engage in the Interactive Process Before Disciplining Medical Marijuana Users Epstein Becker & Green, P.C.
Dec
21
2020
Restrictions on Venue in Hatch-Waxman Litigation Epstein Becker & Green, P.C.
Feb
16
2018
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices Epstein Becker & Green, P.C.
Aug
18
2021
How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture? [PODCAST] Epstein Becker & Green, P.C.
Nov
20
2018
FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies Epstein Becker & Green, P.C.
Mar
4
2019
OIG Evaluates Remote Patient Monitoring Arrangement Epstein Becker & Green, P.C.
Feb
3
2015
Are Lower Cost Drugs Less Effective? It May Depend on the Patient’s Perspective. Epstein Becker & Green, P.C.
Feb
12
2015
Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
Oct
13
2022
Four Years After EKRA: Reminders for Clinical Laboratories Epstein Becker & Green, P.C.
Aug
28
2015
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
Mar
1
2023
Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests Epstein Becker & Green, P.C.
Apr
4
2023
Is CMS Ignoring the Realities of Biopharmaceutical Costs? Epstein Becker & Green, P.C.
Apr
26
2023
The Legal Battle Over Mifepristone Epstein Becker & Green, P.C.
Mar
19
2020
OCR Waives Penalties for Telehealth Communications During COVID-19 National Emergency Epstein Becker & Green, P.C.
Aug
8
2023
The FTC Finalizes Changes to Endorsement Guides Epstein Becker & Green, P.C.
Aug
23
2023
SuperValu’s Effect on the FCA Scienter Standard and Impact to Future Litigation Epstein Becker & Green, P.C.
Sep
5
2023
Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? Epstein Becker & Green, P.C.
Apr
21
2020
FDA Authorizes the First Home Collection of Specimens to be Tested for COVID-19 Epstein Becker & Green, P.C.
Jan
19
2024
Sponsored Genetic Testing Programs: Compliance Considerations Following DOJ False Claims Act Settlement Epstein Becker & Green, P.C.
Aug
12
2020
Be Aware Before You Share: Vetting Third Party Apps Prior to Data Transfer Epstein Becker & Green, P.C.
Mar
8
2024
BioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs Epstein Becker & Green, P.C.
Jan
22
2018
New State Laws Allow Telehealth Prescriptions for Controlled Substances; Yet, Regulatory Obstacles Still Remain Epstein Becker & Green, P.C.
Jul
11
2018
State Attorneys General Investigating Use of Non-Competes by Fast Food Franchisors Epstein Becker & Green, P.C.
Aug
18
2021
Vaccine Mandates, Mandate Bans, Wage and Hour Nomination Stalls – Employment Law This Week [VIDEO] Epstein Becker & Green, P.C.
Oct
19
2018
New Federal Laws Banning “Gag Clauses” in the Pharmacy Epstein Becker & Green, P.C.
Jan
13
2022
CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins